GRISENDI, Giulia
 Distribuzione geografica
Continente #
NA - Nord America 15.977
EU - Europa 8.246
AS - Asia 6.388
SA - Sud America 997
Continente sconosciuto - Info sul continente non disponibili 300
AF - Africa 157
OC - Oceania 54
Totale 32.119
Nazione #
US - Stati Uniti d'America 15.506
SE - Svezia 2.339
IT - Italia 2.269
SG - Singapore 2.072
CN - Cina 1.521
GB - Regno Unito 1.392
VN - Vietnam 732
HK - Hong Kong 720
BR - Brasile 698
DE - Germania 576
RU - Federazione Russa 340
BD - Bangladesh 320
FI - Finlandia 267
FR - Francia 261
CA - Canada 213
UA - Ucraina 179
TR - Turchia 154
ID - Indonesia 149
KR - Corea 142
IN - India 126
MX - Messico 97
NL - Olanda 95
AR - Argentina 92
BG - Bulgaria 84
IE - Irlanda 65
JP - Giappone 61
IQ - Iraq 56
BE - Belgio 55
AU - Australia 52
PL - Polonia 50
ES - Italia 49
EC - Ecuador 46
VE - Venezuela 43
ZA - Sudafrica 43
PK - Pakistan 38
AE - Emirati Arabi Uniti 36
CO - Colombia 35
CL - Cile 30
CR - Costa Rica 27
IL - Israele 27
MY - Malesia 26
UZ - Uzbekistan 26
CZ - Repubblica Ceca 25
AL - Albania 23
AT - Austria 23
CH - Svizzera 22
LT - Lituania 22
RO - Romania 20
MA - Marocco 19
JO - Giordania 18
NP - Nepal 18
PH - Filippine 18
PE - Perù 17
SA - Arabia Saudita 17
KE - Kenya 16
NI - Nicaragua 16
DZ - Algeria 15
EG - Egitto 15
GT - Guatemala 15
PT - Portogallo 15
HN - Honduras 14
IR - Iran 14
TT - Trinidad e Tobago 14
UY - Uruguay 14
BZ - Belize 13
JM - Giamaica 11
KZ - Kazakistan 11
OM - Oman 11
PY - Paraguay 11
AZ - Azerbaigian 10
GP - Guadalupe 10
TN - Tunisia 10
DO - Repubblica Dominicana 9
MD - Moldavia 9
RS - Serbia 9
ET - Etiopia 8
PA - Panama 8
SC - Seychelles 8
BO - Bolivia 7
BY - Bielorussia 7
LB - Libano 7
PR - Porto Rico 7
SI - Slovenia 7
TH - Thailandia 7
TW - Taiwan 7
BB - Barbados 6
DK - Danimarca 6
EE - Estonia 6
SN - Senegal 6
SV - El Salvador 6
CW - ???statistics.table.value.countryCode.CW??? 5
CY - Cipro 5
GR - Grecia 5
LK - Sri Lanka 5
MT - Malta 5
NG - Nigeria 5
SY - Repubblica araba siriana 5
AM - Armenia 4
HR - Croazia 4
HU - Ungheria 4
Totale 31.763
Città #
Ashburn 1.970
Stockholm 1.796
Singapore 1.400
Fairfield 1.345
Santa Clara 1.280
Southend 798
San Jose 791
Chandler 745
Hong Kong 699
Woodbridge 697
Council Bluffs 622
Houston 617
Seattle 488
Cambridge 439
Ann Arbor 422
Wilmington 422
Nyköping 346
Hefei 328
Beijing 318
Modena 315
New York 306
Los Angeles 302
London 273
Dearborn 263
Jacksonville 255
Bologna 224
Ho Chi Minh City 224
Helsinki 200
Hanoi 190
Milan 190
Chicago 183
The Dalles 165
Munich 136
San Diego 134
Seoul 133
Jakarta 121
Frankfurt am Main 108
Shanghai 99
Dallas 91
Princeton 91
Lauterbourg 84
Buffalo 81
Moscow 79
Sofia 78
Izmir 77
São Paulo 75
Parma 68
Rome 68
Fremont 63
Orem 63
Eugene 58
Columbus 57
Dublin 57
Boardman 56
Phoenix 55
Salt Lake City 53
Brussels 48
Montreal 48
Atlanta 46
Tokyo 44
Bremen 42
Toronto 41
Mexico City 40
Guangzhou 38
Denver 37
Warsaw 37
Reggio Emilia 35
Da Nang 34
Newark 33
Nuremberg 33
Brooklyn 32
Chennai 32
Hillsboro 31
San Giuliano Milanese 31
Falls Church 30
Naples 27
Tampa 27
Florence 26
Haiphong 26
Johannesburg 26
Redwood City 26
Amsterdam 25
Elk Grove Village 24
Boston 23
Grafing 23
Manchester 23
Poplar 23
Rio de Janeiro 23
San Francisco 23
Des Moines 22
Lancaster 22
Norwalk 22
Sydney 22
Baghdad 21
Ravenna 21
Redondo Beach 21
Mumbai 20
Portsmouth 20
San José 20
Tashkent 20
Totale 21.886
Nome #
A Novel 3D In Vitro Platform for Pre-Clinical Investigations in Drug Testing, Gene Therapy, and Immuno-oncology. 2.244
CD271 Mediates Stem Cells to Early Progeny Transition in Human Epidermis 529
CD271 Down-Regulation Promotes Melanoma Progression and Invasion in Three-Dimensional Models and in Zebrafish 520
Adipose-derived mesenchymal stem cells as stable source of tumor necrosis factor-related apoptosis-inducing ligand delivery for cancer therapy 501
In vivo editing of the human mutant Rhodopsin gene by electroporation of plasmid-based CRISPR/Cas9 in the mouse retina 473
Adipose stromal/stem cells assist fat transplantation reducing necrosis and increasing graft performance. 455
Soluble TRAIL Armed Human MSC As Gene Therapy For Pancreatic Cancer 449
Inducible Caspase9-mediated suicide gene for MSC-based cancer gene therapy 447
MSC-delivered soluble TRAIl and paclitaxel as novel combinatory treatment for pancreatic adenocarcinoma 442
GMP-manufactured density gradient media for optimized mesenchymal stromal/stem cell isolation and expansion. 440
Mesenchymal stem/stromal cells as a delivery platform in cell and gene therapies 428
MSC and Tumors: Homing, Differentiation and Secretion Influence The Therapeutic Potentials 424
A novel anti-GD2/4-1BB chimeric antigen receptor triggers neuroblastoma cell killing 418
Isolation, characterization, and transduction of endometrial decidual tissue multipotent mesenchymal stromal/stem cells from menstrual blood 411
Suppression of invasion and metastasis of triple-negative breast cancer lines by pharmacological or genetic inhibition of slug activity 405
Targeting GD2-positive glioblastoma by chimeric antigen receptor empowered mesenchymal progenitors 404
Combination of low doses of Enzastaurin and Lenalidomide has synergistic activity in B-non-Hodgkin lymphoma cell lines 397
Altered pH gradient at the plasma membrane of osteosarcoma cells is a key mechanism of drug resistance 392
WISP-2 expression induced by Teriparatide treatment affects in vitro osteoblast differentiation and improves in vivo osteogenesis 386
Mesenchymal progenitors aging highlights a mir-196 switch targeting HOXB7 as master regulator of proliferation and osteogenesis 383
Transportation conditions for prompt use of Ex Vivo expanded and freshly harvested clinical-grade bone marrow mesenchymal stromal/stem cells for bone regeneration 381
Ibrutinib modifies the function of monocyte/macrophage population in chronic lymphocytic leukemia 379
Proposal of a Novel Natural Biomaterial, the Scleral Ossicle, for the Development of Vascularized Bone Tissue In Vitro 368
Correlating tumor-infiltrating lymphocytes and lung cancer stem cells: a cross-sectional study. 366
Mesenchymal progenitors expressing TRAIL induce apoptosis in sarcomas 361
Tumor Stroma Manipulation By MSC 360
Alternative splicing of NF-YA promotes prostate cancer aggressiveness and represents a new molecular marker for clinical stratification of patients 359
An adoptive immuno-gene therapy approach targeting neuroblastoma. 353
Blocking tumor-educated MSC paracrine activity halts osteosarcoma progression 353
Cancer stem-neuroendocrine cells in an atypical carcinoid case report. 353
Arming Mesenchymal Stromal/Stem Cells Against Cancer: Has the Time Come? 350
In vitro anti-myeloma activity of TRAIL-expressing adipose-derived mesenchymal stem cells. 345
Expression of HOXB7 in the lung of patients with idiopathic pulmonary fibrosis: a proof of concept study. 344
METHOD FOR PRODUCTION OF ANTI-TUMOR TRAIL PROTEIN 336
Detection of microparticles from human red blood cells by multiparametric flow cytometry 335
Inhibiting interactions of lysine demethylase LSD1 with Snail/Slug blocks cancer cell invasion. 335
Cancer Stem-Like Cells in a Case of an Inflammatory Myofibroblastic Tumor of the Lung. 334
Phosphorylation of serine 21 modulates the proliferation inhibitory more than the differentiation inducing effects of C/EBPα in K562 cells. 333
Understanding Tumor-Stroma Interplays for Targeted Therapies by Armed Mesenchymal Stromal Progenitors: The Mesenkillers. 325
Anti-GD2 CAR MSCs against metastatic Ewing's sarcoma 323
GD2 CAR T cells against human glioblastoma 313
Isolation and Identification of Cancer Stem-Like Cells in Adenocarcinoma and Squamous Cell Carcinoma of the Lung: A Pilot Study 310
Mesenchymal Stromal/Stem Cells from Tissue Repair to Destruction of Tumor Cells 306
Alternative splicing of NF-YA promotes prostate cancer aggressiveness and represents a new molecular marker for clinical stratification of patients 306
CD44+/EPCAM+ cells detect a subpopulation of ALDHhigh cells in human non-small cell lung cancer: A chance for targeting cancer stem cells? 305
Effects of Enzastaurin, Alone or in Combination, on Signalling Pathway Controlling Growth and Survival of B-Cell Lymphoma Cell LinesBlood (ASH Annual Meeting Abstracts), Nov 2008; 112: 4978 304
Effects of enzastaurin, alone or in combination, on signaling pathway controlling growth and survival of B-cell lymphoma cell lines. 302
Impact of HOXB7 overexpression on human adipose-derived mesenchymal progenitors 298
IGF-1-mediated osteoblastic niche expansion enhances long-term hematopoietic stem cell engraftment after murine bone marrow transplantation 295
Dietary evaluation and metabolic alterations in HIV-related lipodystrophy 293
Challenges in Clinical Development of Mesenchymal Stromal/Stem Cells: Concise Review 293
A 3D Platform to Investigate Dynamic Cell-to-Cell Interactions Between Tumor Cells and Mesenchymal Progenitors 293
Resistance to neoplastic transformation of ex-vivo expanded human mesenchymal stromal cells after exposure to supramaximal physical and chemical stress 292
Surrounding pancreatic adenocarcinoma by killer mesenchymal stromal/stem cells 290
Autologous Marrow Mesenchymal Stem Cell Driving Bone Regeneration in a Rabbit Model of Femoral Head Osteonecrosis 285
Impact of soluble tumor necrosis factor-related apoptosis-inducing ligand released by engineered adipose mesenchymal stromal cells on white blood cells 279
Human Herpes simplex 1 virus infection of endometrial decidual tissue-derived MSC alters HLA-G expression and immunosuppressive functions 277
CRISPR-mediated T cell engineering against Non-Small Cell Lung Cancer 276
Scleral ossicles as natural biomaterials on which vascular-like network is promoted from Mouse Aortic Endothelial cells (MAECs): preliminary results 270
Immunotherapy: ANTI-GD2 CAR T CELLS AGAINST SMALL CELL LUNG CANCER 268
TRAIL receptors are expressed in both malignant and stromal cells in pancreatic ductal adenocarcinoma 265
Inhibition of ERK1/2 signaling prevents bone marrow fibrosis by reducing osteopontin plasma levels in a myelofibrosis mouse model 265
In vitro and in vivo discrepancy in inducing apoptosis by mesenchymal stromal cells delivering membrane-bound tumor necrosis factor–related apoptosis inducing ligand in osteosarcoma pre-clinical models 261
Therapeutic potential of the metabolic modulator phenformin in targeting the stem cell compartment in melanoma 261
Challenging the efficacy of checkpoint inhibitors: a new 3D model for a precision medicine approach. 259
Author Correction: A Novel 3D In Vitro Platform for Pre-Clinical Investigations in Drug Testing, Gene Therapy, and Immuno-oncology (Scientific Reports, (2019), 9, 1, (7154), 10.1038/s41598-019-43613-9) 258
Impact of Mesenchymal Stromal/stem Cell Infusions on Circulating Inflammatory Biomarkers in COVID-19 Patients: Analysis of a Phase I-IIa Trial. 257
Cancer stem cells and macrophages: molecular connections and future perspectives against cancer. 256
TRAIL delivered by mesenchymal stromal/stem cells counteracts tumor development in orthotopic Ewing sarcoma models 252
Cancer stem cells and their microenvironment. 251
New Perspectives in Different Gene Expression Profiles for Early and Locally Advanced Non-Small Cell Lung Cancer Stem Cells. 249
Role of mesenchymal stem cells in osteosarcoma and metabolic reprogramming of tumor cells 246
Staminali per la cura del tumore del pancreas: tra evidenze scienti che e possibile trasferimento clinico 242
Immunotherapy: AUTOLOGOUS ANTI-GD2 CAR T CELLS EFFICIENTLY TARGET PRIMARY HUMAN GLIOBLASTOMA 240
Stem cells and lung cancer : between advanced diagnostics and new therapeutics. 239
Deepening the knowledge of ros1 rearrangements in non-small cell lung cancer: Diagnosis, treatment, resistance and concomitant alterations 239
Combining gemcitabine and MSC delivering soluble TRAIL to target pancreatic adenocarcinoma and its stroma 237
Carbonic anhydrase IX inhibition is an effective strategy for osteosarcoma treatment 236
Sarcomas as a mise en abyme of Mesenchymal Stem Cells; exploiting interrelationships for cell mediated anticancer therapy 228
Refining GMP-manufactured density gradient media for optimised mesenchymal stromal/stem cell isolation and expansion. 219
Cancer Stem Cells and Cell Cycle Genes as Independent Predictors of Relapse in Non-small Cell Lung Cancer: Secondary Analysis of a Prospective Study 219
Human Adipose Mesenchymal Stromal/Stem Cells Improve Fat Transplantation Performance 216
Genetic Engineering as a Strategy to Improve the Therapeutic Efficacy of Mesenchymal Stem/Stromal Cells in Regenerative Medicine 206
Adoptive CAR T Cell Therapy Targeting GD2-Positive Cancers 201
CRISPR-Mediated Genome Editing to Redirect T Cells against Non-Small Cell Lung Cancer 198
Abstract A17: Challenging pancreatic ductal adenocarcinoma and its stroma by a combination of chemo and gene therapy: A preclinical study 195
CRISPR-mediated genome editing to redirect T cells against Non-Small Cell Lung Cancer 194
Dissecting Tumor Growth: The Role of Cancer Stem Cells in Drug Resistance and Recurrence 191
CAR-modified killer MSC targeting GD2-positive Ewing sarcoma 190
The release of inflammatory mediators from acid-stimulated mesenchymal stromal cells favours tumour invasiveness and metastasis in osteosarcoma 186
Anti-GD2 chimeric antigen receptor & trail modified mesenchymal progenitors as novel strategy against ewing’s sarcoma 178
CRISPR-mediated genome editing to redirect T cells against Non-Small Cell Lung Cancer 173
The Influence of Cancer Stem Cells on the Risk of Relapse in Adenocarcinoma and Squamous Cell Carcinoma of the Lung: A Prospective Cohort Study 171
Bone marrow derived mesenchymal stem/stromal cells transduced with full length human TRAIL repress the growth of rhabdomyosarcoma cells in vitro 168
Persistency of Mesenchymal Stromal/Stem Cells in Lungs 158
Acid microenvironment promotes cell survival of human bone sarcoma through the activation of cIAP proteins and NF-κB pathway 157
5P Anti-GD2 chimeric antigen receptor & TRAIL modified mesenchymal progenitors as novel strategy against Ewing’s sarcoma 150
Modulating endothelial adhesion and migration impacts stem cell therapies efficacy 148
Targeting Cancer Stem Cells: New Perspectives for a Cure to Cancer 134
The molecular features of lung cancer stem cells in dedifferentiation process-driven epigenetic alterations 131
Totale 31.920
Categoria #
all - tutte 116.603
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 116.603


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.553 0 0 0 0 78 123 177 145 216 163 414 237
2022/20232.267 259 278 189 241 231 265 63 216 260 26 124 115
2023/20241.494 101 88 113 155 280 181 102 138 36 51 71 178
2024/20255.067 144 90 184 372 850 859 501 263 527 254 402 621
2025/202611.389 633 332 669 1.134 1.592 559 1.170 470 2.678 993 719 440
2026/20272.725 263 547 598 1.087 230 0 0 0 0 0 0 0
Totale 32.119